Business, Financial and Leadership Highlights (The Manila Times) - Aug 15, 2026 - "CUE-221...Phase 2 data readout in Chronic Spontaneous Urticaria anticipated by the end of the third quarter of 2026...CUE-401: Company anticipates submitting an IND to the FDA and initiating a Phase 1 clinical study by year-end 2026."
IND • New P1 trial • P2 data • Chronic Spontaneous Urticaria • Food Hypersensitivity • Immunology
|